Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Compulsive Behavior

• Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders
• The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms
• Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvement
• The Study of Mindfulness Based Cognitive Therapy and Obsessive-Compulsive Disorder
• Mindfulness-Based Cognitive Therapy: Efficacy and fMRI-based Response Predictors in a Group of OCD Patients
• Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder
• Cannabinoid Medication for Adults With OCD
• Glutathione Levels and Compulsivity
• Brief Intervention for OCD Fears
• The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive Disorder
• Oxytocin Administration in BDD and OCD
• Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients?
• Understanding How Ketamine Brings About Rapid Improvement in OCD
• Deep Brain Stimulation of NAc/ALIC to Prevent Treatment-Refractory Obsessive Compulsive Disorder
• Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
• Pharmaco(Epi)Genetic Study of Obsessive-Compulsive Disorder
• Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)
• Music Therapy in Obsessive Compulsive Disorder
• The Gut Microbiota in Obsessive-Compulsive Disorder
• Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder
• A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
• Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD
• Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder
• Trial of Low-Dose Xenon For The Treatment Of Obsessive-Compulsive Disorder
• Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)
• Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
• A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder
• Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy
• Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD
• The Use of D-Cycloserine to Augment CBT for Pediatric OCD
• A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)
• D-Cycloserine as an Adjunct to Internet-CBT for OCD
• Antibiotic Treatment Trial for the PANDAS/PANS Phenotype
• Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder
• D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
• Predicting Medication Response in Obsessive Compulsive Disorder
• 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD
• Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
• Ketamine Infusion for Obsessive-Compulsive Disorder
• Ondansetron Augmentation in Treatment-resistant OCD
• Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)
• Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
• D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD
• N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder
• Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder.
• Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
• Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)
• Marinol in Trichotillomania or Obsessive Compulsive Disorder
• N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)
• A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder
• A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder
• Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder
• D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder
• Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
• Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)
• Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
• Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)
• Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)
• Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive Disorder
• Treatment Youth With Obsessive-Compulsive Disorder
• Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Practical Trial
• Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
• Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
• Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder
• Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder
• Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients
• N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
• Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
• Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)
• To Investigate If Single Doses Of GSK618334 Are Safe And To Investigate Blood Levels Of GSK618334
• Repetitive Behavior Disorders in People With Severe Mental Retardation
• Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors
• Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment
• Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)
• Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809
• Adjunctive Glycine for Obsessive Compulsive Disorder
• Antidepressant Safety in Kids Study
• Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder
• Effectiveness of Sertraline and Cognitive Behavioral Therapy in Treating Pediatric Obsessive-Compulsive Disorder
• Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)
• Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCD
• Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents
• Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety
• Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study
• Tolerability and Efficacy of High Dose Escitalopram for the Treatment of Obsessive-Compulsive Disorder (OCD)
• Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder
• An Open-Label Study Of Lamictal In Neurotic Excoriation
• Memantine Augmentation in Obsessive-Compulsive Disorder
• D-Cycloserine Augmentation of Exposure and Response Prevention Treatment for Obsessive-Compulsive Disorder
• Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
• Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders
• Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients
• Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
• Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder
• Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder
• Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
• Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder
• Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
• Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)
• Effectiveness of D-Cycloserine as an Aid to Enhance Learning for Individuals With OCD Receiving Behavior Therapy
• A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder
• Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
• Treatment of Obsessive Compulsive Disorder in Children
• St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder.
• Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder
• Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections
• Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup)
• Treatment for Anxiety in Children
• Treatment of Obsessive-Compulsive Disorder (OCD) in Children
• Treatment of Obsessive-Compulsive Disorder